In rheumatoid arthritis (RA), type III interferon can ameliorate joint inflammation by inhibiting the number of proinflammatory IL-17-producing Th17 and γδ T cells, as well as IL-1β-positive neutrophils in the joints and inguinal lymph nodes. The gene discussed is IL17A; the disease is rheumatoid arthritis.